BIOEQUIVALENCE OF FIXED-DOSE COMBINATIONS OF DAPAGLIFLOZIN/METFORMIN RELATIVE TO SINGLE COMPONENTS IN HEALTHY SUBJECTS

被引：0
|
作者：
Boulton, D. W. [1 ]
Chang, M. [1 ]
Griffen, S. C. [2 ]
Kitaura, C. [1 ]
Lubin, S. [1 ]
Pollack, A. [1 ]
LaCreta, F. [1 ]
机构：
[1] Bristol Myers Squibb Co, Princeton, NJ USA
[2] JDRF, New York, NY USA
来源：
CLINICAL THERAPEUTICS | 2015年 / 37卷 / 08期
关键词：
D O I：
10.1016/j.clinthera.2015.05.283
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：E98 / E99
页数：2
相关论文
共 50 条
  • [41] Bioequivalence evaluation of two amlodipine salts, besylate and orotate, each in a fixed-dose combination with olmesartan in healthy subjects
    Lee, Soo-Yun
    Kim, Jung-Ryul
    Jung, Jin Ah
    Huh, Wooseong
    Bahng, Mi Young
    Ko, Jae-Wook
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2015, 9 : 2811 - 2817
  • [42] The Bioequivalence and Effect of Food on the Pharmacokinetics of a Fixed-Dose Combination Tablet Containing Rosuvastatin and Ezetimibe in Healthy Japanese Subjects
    Nishida, Chisato
    Matsumoto, Yuki
    Fujimoto, Katsukuni
    Shirakawa, Masayoshi
    Wrishko, Rebecca Ellen
    Behm, Martin Otto
    Furihata, Kenichi
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2019, : 704 - 712
  • [43] PHARMACOKINETICS AND PHARMACODYNAMICS OF A FIXED-DOSE COMBINATION OF GEMIGLIPTIN AND METFORMIN COMPARED TO LOOSE COMBINATION IN HEALTHY SUBJECTS.
    Jin, X.
    Kim, E.
    Rhee, S. -J.
    Hwang, I.
    Kim, Y.
    Lee, H.
    Yu, K. -S.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 105 : S100 - S100
  • [44] A PHARMACOKINETIC COMPARISON BETWEEN FIXED-DOSE COMBINATION AND SEPARATE TABLETS OF ROSUVASTATIN AND METFORMIN IN FED STATE AND FOOD EFFECT OF FIXED-DOSE COMBINATION IN HEALTHY SUBJECTS.
    Kim, E.
    Rhee, S-J.
    Kim, Y.
    Oh, J.
    Suh, H.
    Lee, Y.
    Lee, Y.
    Cho, J-Y.
    Yu, K-S.
    Lee, H.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 103 : S40 - S40
  • [45] Evaluation of rifampicin bioequivalence in fixed-dose combinations using the WHO/IUATLD recommended protocol
    Panchagnula, R
    Agrawal, S
    Kaur, KJ
    Singh, I
    Kaul, CL
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2000, 4 (12) : 1169 - 1172
  • [46] Pharmacokinetics and Bioequivalence of a Generic Fixed-Dose Combination Tablet of Metformin Hydrochloride/Vildagliptin Versus a Branded Product in Healthy Chinese Subjects Under Fed and Fasting Conditions
    Ye, LiJun
    Li, Bei
    Ling, NengMing
    Gao, Yue
    Tao, XueXia
    Cai, ShuFan
    Wang, Yan
    Chen, ShaoChun
    Wang, Fei
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2022, 11 (01): : 63 - 70
  • [47] BIOEQUIVALENCE OF FIXED DOSE COMBINATION (FDC) TABLETS OF LINAGLIPTIN/METFORMIN EXTENDED RELEASE COMPARED WITH THE FREE COMBINATIONS IN HEALTHY VOLUNTEERS
    Lippert, C.
    Sennewald, R.
    Bell, J.
    Wiebe, S.
    Huettner, S.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 99 : S32 - S32
  • [48] Fixed-dose combinations in type 2 diabetes - role of the canagliflozin metformin combination
    Fleming, Joshua W.
    Fleming, Laurie W.
    Davis, Courtney S.
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2015, 8 : 287 - 294
  • [49] Pharmacokinetic Comparison Between a Fixed-Dose Combination of Empagliflozin L-Proline/Metformin and Empagliflozin/Metformin in Healthy Korean Subjects
    Lee, HyunJoon
    Chung, Jae-Yong
    Yu, Kyung-Sang
    Park, Shin-Jung
    Lee, Soyoung
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2023, 12 (12): : 1156 - 1163
  • [50] Pharmacokinetic Bioequivalence Studies of a Fixed-Dose Combination of Tamsulosin and Dutasteride in Healthy Volunteers
    Fossler, Michael J.
    Collins, David A.
    Thompson, Meg M.
    Nino, Antonio
    Bianco, Joseph J.
    Chetty, Dushen
    CLINICAL DRUG INVESTIGATION, 2014, 34 (05) : 335 - 349
12345